CDC releases clinical guidance on e-cigarette lung injury

CDC releases clinical guidance on E-cigarette lung injury

(HealthDay)—In an early-release Oct. 11 issue of the U.S. Centers for Disease Control and Prevention Morbidity and Mortality Weekly Report, the CDC presents interim guidance to help clinicians assess, evaluate, manage, and follow patients with electronic cigarette, or vaping, product use-associated lung injury (EVALI).

David A. Siegel, M.D., from the CDC in Atlanta, and colleagues assessed national surveillance data regarding clinical features of recently reported cases of EVALI. The authors then updated interim recommendations based on these data for U.S. caring for patients with suspected or known EVALI.

The interim guidance recommends that health care providers evaluating patients suspected to have EVALI ask about the use of e-cigarette, or vaping, products in "a nonjudgmental and thorough manner." Patients suspected of having EVALI should have a chest radiograph. Hospital admission is recommended for patients with decreased blood oxygen saturation (<95 percent) on room air or who are in respiratory distress. Empiric use of a combination of antibiotics, antivirals, or steroids should be considered based on clinical context. To help patients discontinue use of e-cigarette, or vaping, products, evidence-based tobacco product cessation strategies are recommended. Patients who have been treated for EVALI should not use e-cigarette, or vaping, products to reduce the risk for recurrence.

"Rapid recognition by health care providers of patients with EVALI and an increased understanding of treatment considerations could reduce morbidity and mortality associated with this injury," the authors write.

More information: Abstract/Full Text

Copyright © 2019 HealthDay. All rights reserved.

Citation: CDC releases clinical guidance on e-cigarette lung injury (2019, October 15) retrieved 30 November 2023 from
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.

Explore further

Patients back in hospital after 'EVALI' vaping illness


Feedback to editors